| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Xu,Qiang | Chairman | 43.81% | CTCI CORPORATION |
| Lv,Xue-Jin | Director | 0.00% | |
| Zhan,Huo-Sheng | Director | 0.00% | |
| Chen,Bao-Lang | Director | 0.00% | |
| Chen,Hong-Yi | Director | 2.07% | |
| Wu,Guo-An | Director | 43.81% | CTCI CORPORATION |
| Chen,Xiong-Wen | Independent Director | 0.00% | |
| Zhan,Wen-Nan | Independent Director | 0.00% | |
| Su,Nai-Hui | Independent Director | 0.00% |
Change Person in Charge to Xu,Qiang
2024/06/21
Change Capital to 500,000,000
2021/08/18
Change Person in Charge to Wu,Guo-An
2021/01/21
Change Person in Charge to Zhou,Zhong-Qi
2020/07/03
Change Capital to 300,000,000
2020/06/03
Change Person in Charge to Yu,Teng-Yao
2018/12/26
Change Person in Charge to Chen,Zhen-Qin
2017/07/21
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 1,094,757 | 6,395,020 | 6,770,194 |
| Operating cost | 1,009,363 | 5,823,099 | 6,239,937 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 85,394 | 571,921 | 530,257 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 85,394 | 571,921 | 530,257 |
| Operating expenses | 37,931 | 147,767 | 130,820 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 47,463 | 424,154 | 399,437 |
| Non-operating income and expenses | 7,145 | 43,646 | 36,216 |
| Net profit (loss) before tax | 54,608 | 467,800 | 435,653 |
| Income tax expense (benefits) | 10,041 | 88,873 | 84,885 |
| Net profit (loss) of ongoing business for the current period | 44,567 | 378,927 | 350,768 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 44,567 | 378,927 | 350,768 |
| Other comprehensive profit (loss), net | 1,569 | 11,232 | -2,309 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 46,136 | 390,159 | 348,459 |
| Net profit (loss) attributable to owners of parent company | 44,567 | 378,927 | 350,768 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | 0 | 0 | 0 |
| Comprehensive profit (loss) attributable to owners of parent company | 46,136 | 390,159 | 348,459 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | 0 | 0 | 0 |
| Basic earnings per share (yuan) | 1 | 13 | 12 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 303,048 | 1,387,162 | -264,904 |
| Net cash inflows (outflows) from investing activities | 47 | -5,331 | 69,391 |
| Net cash inflow (outflow) from financing activities | -8,122 | -496,923 | 239,522 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 444 | 1,102 | -604 |
| Increase (decrease) in cash and cash equivalents in the current period | 295,417 | 886,010 | 43,405 |
| Beginning balance of cash and cash equivalents | 1,573,252 | 687,242 | 643,837 |
| Ending balance of cash and cash equivalents | 1,868,669 | 1,573,252 | 687,242 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 4,468,495 | 4,672,707 | 4,400,430 |
| Non-current asset | 386,282 | 393,091 | 423,124 |
| Total asset | 4,854,777 | 5,065,798 | 4,823,554 |
| Current liability | 3,607,965 | 3,542,195 | 3,360,247 |
| Non-current liability | 523,931 | 526,617 | 561,806 |
| Total liability | 4,131,896 | 4,068,812 | 3,922,053 |
| share capital | 284,781 | 284,287 | 281,342 |
| Equity - secruity token | - | - | - |
| capital reserve | 218,800 | 217,447 | 216,916 |
| retained earning | 217,452 | 494,916 | 400,873 |
| Other equity | 1,845 | 333 | 2,370 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 722,878 | 996,983 | 901,501 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 3 | 3 | 0 |
| Total Equity | 722,881 | 996,986 | 901,501 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 27,193 | 14,500 | 5,500 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 25 | 35 | 32 |
Others
2004, 2011
Pay salary
2017, 2018, 2019
Litigation aid
2010
Compensation for damage
2010, 2011
Restitution of unjust enrichment
2008
Others
2002, 2003, 2007
Payment order
2019
Pay the ticket
2002
Return deposit
2022
Pay for the goods
2019
Pay the ticket, etc.
2000, 2001
Invalidating Judgment
2006, 2009
Compensation for damage
2002, 2003, 2004, 2005, 2006, 2013, 2014, 2016
Determine legal expenses
2012
Pay contract remuneration
2008, 2010, 2011
Request for damage compensation
2016
Retrial for damage compensation
2017
Pay the buying and selling price
2004, 2005
Restitution of unjust enrichment
2009, 2010
Petition filed for public summons
2008, 2009
Restitution of unjust enrichment, etc.
2012, 2015, 2016, 2017, 2018, 2021, 2022
Commercial Arbitration Enforcement Ruling
2003
Request for restitution of unjust enrichment, etc.
2020, 2022
Request for damage compensation, etc. Approval of Third Instance Attorney's Remuneration
2017
